pLL3.7_hsa-miR-34a Citations (4)

Originally described in: miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, Lieberman J Blood. 2009 Sep 3. 114(10):2181-92. PubMed Journal

---

Articles Citing pLL3.7_hsa-miR-34a

Articles
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Pyzer AR, Stroopinsky D, Rajabi H, Washington A, Tagde A, Coll M, Fung J, Bryant MP, Cole L, Palmer K, Somaiya P, Karp Leaf R, Nahas M, Apel A, Jain S, McMasters M, Mendez L, Levine J, Joyce R, Arnason J, Pandolfi PP, Kufe D, Rosenblatt J, Avigan D. Blood. 2017 Mar 30;129(13):1791-1801. doi: 10.1182/blood-2016-07-730614. Epub 2017 Jan 26. PubMed
Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis. Iwagami Y, Zou J, Zhang H, Cao K, Ji C, Kim M, Huang CK. J Cell Mol Med. 2018 Jun 5. doi: 10.1111/jcmm.13681. PubMed
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP, Rieger S, Kempkes B, Coccia EM, Sui SJH, Chen CS, Uccini S, Avigan D, Faggioni A, Trivedi P, Slack FJ. Leukemia. 2019 Jan;33(1):132-147. doi: 10.1038/s41375-018-0178-x. Epub 2018 Jun 26. PubMed
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Wu X, Cheng YL, Matthen M, Yoon A, Schwartz GK, Bala S, Taylor AM, Momen-Heravi F. J Exp Clin Cancer Res. 2021 Feb 17;40(1):70. doi: 10.1186/s13046-021-01865-2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.